Search

Author/Creator Reyderman, Larisa

14. Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug‐Drug Interaction Study in Healthy Females. Issue 9 (9th June 2021)

Authors:
Landry, Ishani; Aluri, Jagadeesh; Hall, Nancy; Filippov, Gleb; Dayal, Satish; Moline, Margaret; Reyderman, Larisa
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 9(2021)
Page Start:
1089
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Evaluation of the CYP3A and CYP2B6 Drug‐Drug Interaction Potential of Lemborexant. Issue 6 (17th January 2021)

Authors:
Landry, Ishani; Aluri, Jagadeesh; Nakai, Kenya; Hall, Nancy; Miyajima, Yukiko; Ueno, Takashi; Dayal, Satish; Filippov, Gleb; Lalovic, Bojan; Moline, Margaret; Reyderman, Larisa
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 6(2021)
Page Start:
681
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Exposure–Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia. (17th January 2023)

Authors:
Lalovic, Bojan; Savant Landry, Ishani; Moline, Margaret; Reyderman, Larisa; Hussein, Ziad
Journal:
Journal of clinical pharmacology
Issue:
Volume 63:Number 4(2023)
Page Start:
498
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers. Issue 1 (17th June 2020)

Authors:
Hong, David S; Parikh, Aparna; Shapiro, Geoffrey I; Varga, Andrea; Naing, Aung; Meric-Bernstam, Funda; Ataman, Özlem; Reyderman, Larisa; Binder, Terri A; Ren, Min; Liu, Mingjie; Dayal, Satish; Siu, Amy Y; Sachdev, Pallavi; Xu, Lucy; Bhagawati-Prasad, Vijay; Tchakov, Ilian; Ooi, Chean Eng; Bao, Xi...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. Lecanemab (BAN2401) Infusion Reactions and Immunogenicity: Results from Randomized Phase 2 Study and an Open‐Label Extension (OLE). (20th December 2022)

Authors:
Landry, Ishani; Kanekiyo, Michio; Aluri, Jagadeesh; Li, David JianJun; Hussein, Ziad; Reyderman, Larisa; Dhadda, Shobha; Swanson, Chad J; Irizarry, Michael C; Kramer, Lynn D
Journal:
Alzheimer's & dementia
Issue:
Volume 18(2022)Supplement 10
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗